The CytoSure Cancer +SNP array delivers:
• Flexible choice of reference sample
• Confident detection of CNV and LOH on a single array
• An optimised design allowing identification of key genomic aberrations
• Cancer-specific tracks enabling fast and easy data generation and interpretation of cytogenetic results
The CytoSure Cancer +SNP array combines long oligo array comparative genomic hybridisation (aCGH) for superior detection of copy number changes with fully research-validated single nucleotide polymorphism (SNP) content for accurate identification of loss of heterozygosity (LOH) without concurrent changes in copy number. The SNP content has been independently developed at OGT and utilises unique SNP chemistry. The array content has been optimised in collaboration with Dr Jacqueline Schoumans, Head of the Cancer Cytogenetic Unit at Lausanne University Hospital, to target regions known to be important when researching disease progression. The complimentary, industry-leading CytoSure Interpret Software allows intuitive, single-click data analysis